NCCAM PC-SPES Clinical Research Could Resume With “Clean” Product
This article was originally published in The Tan Sheet
Executive Summary
NIH's National Center for Complementary & Alternative Medicine could resume funding clinical research on PC-SPES if an independent manufacturer is able to develop an uncontaminated version of the proprietary herbal blend, NCCAM Director Stephen Straus, MD, suggested at the center's advisory council meeting in Rockville, Md. Aug. 26
You may also be interested in...
The Institute of Medicine's Committee on the Use of Complementary & Alternative Medicine by the American Public should evaluate the different qualifications and knowledge sets CAM researchers bring to the study environment, NCCAM Director Stephen Straus, MD, said at the group's inaugural meeting in Washington, D.C. Feb. 27
The Institute of Medicine's Committee on the Use of Complementary & Alternative Medicine by the American Public should evaluate the different qualifications and knowledge sets CAM researchers bring to the study environment, NCCAM Director Stephen Straus, MD, said at the group's inaugural meeting in Washington, D.C. Feb. 27
The Institute of Medicine's Committee on the Use of Complementary & Alternative Medicine by the American Public should evaluate the different qualifications and knowledge sets CAM researchers bring to the study environment, NCCAM Director Stephen Straus, MD, said at the group's inaugural meeting in Washington, D.C. Feb. 27
Existing Subscriber?
Sign in to continue reading.
Need a specific report?
1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests: